Skip to main content
. 2020 May 16;20:190. doi: 10.1186/s12883-020-01771-8

Table 3.

Evolution of hemodynamic and metabolic parameters in patients who presented a first episode of hyponatremia over the study period (N = 16)

Day of hyponatremia Day - 1 Day - 2
Natremia (mmol/L) 135 [134–135] 138 [137–139] 141 [139–144] *,
Fluid intake (L/24 h) 3.0 [2.5–3.3] 2.5 [2.3–3.0] 2.7 [2.6–3.0]
Diuresis (L/24 h) 2.2 [2.0–3.1] 2.3 [1.7–3.2] 2.2 [1.9–2.6]
Fluid balance (L/24 h) 0.6 [− 0.1–1.0] 0.5 [− 0.8–0.9] 0.4 [−0.2–1.0]
Sodium intake (mmol/24 h) 356 [297–425] 278 [224–363] 288 [252–319] *
Urinary sodium excretion (mmol/24 h) 316 [178–452] 372 [288–553] 403 [297–466]
Sodium balance (mmol/24 h) 87 [− 97–148] − 98 [− 211–74] −130 [− 213 – − 2]
24-h CLCR(ml/min/1.73m2) 145 [127–165] 161 [139–173] 141 [128–163]
Urinary osmolality (mmol/L) 595 [491–686] 551 [498–712] 636 [483–740]
24-h CLH2O(ml/min/1.73m2) - 1.6 [−1.9 – − 1.3] - 1.6 [− 1.9 – − 1.3] - 1.8 [− 2.0 – − 1.1]
Fractional excretion of sodium (%) 1.04 [0.52–1.80] 0.95 [0.81–2.27] 1.15 [0.99–1.63]
Fractional excretion of urate (%) 27 [15–28] 21 [14–27] 23 [16–25] *
BUN (mmol/L) 4.9 [3.3–6.3] 4.1 [2.5–5.2] 3.0 [2.3–4.6] *
Protidemia (g/L) 65 [60–67] 62 [58–68] 58 [53–63] *,
Hte (%) 32 [29–36] 33 [30–35] 31 [30–35]
Mean MAP (mmHg) 92 [86–98] 94 [91–94] 91 [87–94]
Use of vasopressor 5 (31) 8 (50) 8 (50)

Data expressed as median [interquartile 25–75] and numbers (percentages)

* = p < 0.05 between Day − 2 and Day 0; † = p < 0.05 between Day − 2 and Day − 1 (continuous variables compared using Wilcoxon test for paired samples)